JPRN-UMIN000049908尚未招募Unknown
Safety evaluation in an open-label study of an overdose of the capsules containing Valeriana fauriei root (VF) extract. - Safety evaluation of the capsules containing VF extract.
agoya City University Hospital0 个研究点目标入组 10 人开始时间: 2022年12月27日最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Subjects currently being treated for severe renal or liver disease, heart, respiratory or endocrine disease, or other metabolic diseases. 2. Subjects currently taking medications that interfere with sleep (sleeping pills, antianxiety drugs) 3. Subjects allergic to gelatin. 4. Women having the possibility or intention to become pregnant, lactating
研究者
相似试验
进行中（未招募）
1 期
A study to evaluate the safety of REN001 capsules when given for 12 weeks (with option to continue treatment) to patients with mitochondrial myopathies.EUCTR2018-002969-19-GBReneo Pharma Ltd.24
进行中（未招募）
1 期
An open-label study to characterize the safety and response rate of MabThera (Rituximab) plus chlorambucil in previously untreated patients with CD20-positive B-cell chronic lymphocytic leukemia. - not applicableCD20-positive B-cell chronic lymphocytic leukemiaEUCTR2007-000172-16-GBF. Hoffmann-La Roche Limited100
进行中（未招募）
不适用
A Study Assessing 13-valent Pneumococcal Conjugate Vaccine in Healthy Chinese SubjectsPneumococcal InfectionMedDRA version: 17.1Level: PTClassification code 10061353Term: Pneumococcal infectionSystem Organ Class: 10021881 - Infections and infestationsEUCTR2014-004180-20-Outside-EU/EEAPfizer Inc72
进行中（未招募）
1 期
A phase Ib/II open-label study evaluating safety and efficacy of oral BKM120 in combination with lapatinib in HER2+/PI3K-activated, trastuzumab-resistant locally advanced, recurrent and metastatic breast cancer. - PIKHER2locally advanced, recurrent and metastatic breast cancer.MedDRA version: 14.1Level: LLTClassification code 10027475Term: Metastatic breast cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-002167-23-FRInstitut Paoli-Calmettes59
进行中（未招募）
1 期
An open-label clinical study to evaluate the safety and antiepileptic activity of ganaxolaone in treatment of patients diagnosed with infantile spansms.EUCTR2006-004286-33-PLMarinus Pharmceuticals, Inc.54